146 related articles for article (PubMed ID: 34141331)
1. Metyrosine treatment in a woman with chromosome 22q11.2 deletion syndrome and psychosis: a case study.
Engebretsen MH; Kildahl AN; Hoy IH; Bakken TL
Int J Dev Disabil; 2017 Nov; 65(2):116-121. PubMed ID: 34141331
[No Abstract] [Full Text] [Related]
2. Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report.
Carandang CG; Scholten MC
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):115-20. PubMed ID: 17343559
[TBL] [Abstract][Full Text] [Related]
3. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis.
O'Rourke L; Murphy KC
Curr Opin Psychiatry; 2019 Mar; 32(2):67-72. PubMed ID: 30394904
[TBL] [Abstract][Full Text] [Related]
6. Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls.
Frascarelli M; Accinni T; Buzzanca A; Carlone L; Ghezzi F; Moschillo A; Kotzalidis GD; Bucci P; Giordano GM; Fanella M; Di Bonaventura C; Putotto C; Marino B; Pasquini M; Biondi M; Di Fabio F
J Neuropsychol; 2023 Sep; 17(3):564-583. PubMed ID: 37159847
[TBL] [Abstract][Full Text] [Related]
7. Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
Bassett AS; Lowther C; Merico D; Costain G; Chow EWC; van Amelsvoort T; McDonald-McGinn D; Gur RE; Swillen A; Van den Bree M; Murphy K; Gothelf D; Bearden CE; Eliez S; Kates W; Philip N; Sashi V; Campbell L; Vorstman J; Cubells J; Repetto GM; Simon T; Boot E; Heung T; Evers R; Vingerhoets C; van Duin E; Zackai E; Vergaelen E; Devriendt K; Vermeesch JR; Owen M; Murphy C; Michaelovosky E; Kushan L; Schneider M; Fremont W; Busa T; Hooper S; McCabe K; Duijff S; Isaev K; Pellecchia G; Wei J; Gazzellone MJ; Scherer SW; Emanuel BS; Guo T; Morrow BE; Marshall CR;
Am J Psychiatry; 2017 Nov; 174(11):1054-1063. PubMed ID: 28750581
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review.
Mosheva M; Korotkin L; Gur RE; Weizman A; Gothelf D
Eur Child Adolesc Psychiatry; 2020 Aug; 29(8):1035-1048. PubMed ID: 30949827
[TBL] [Abstract][Full Text] [Related]
9. White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis.
Kates WR; Olszewski AK; Gnirke MH; Kikinis Z; Nelson J; Antshel KM; Fremont W; Radoeva PD; Middleton FA; Shenton ME; Coman IL
Schizophr Res; 2015 Jan; 161(1):76-84. PubMed ID: 25066496
[TBL] [Abstract][Full Text] [Related]
10. A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?
Vergaelen E; Schiweck C; Van Steeland K; Counotte J; Veling W; Swillen A; Drexhage H; Claes S
Brain Behav Immun; 2018 May; 70():88-95. PubMed ID: 29567371
[TBL] [Abstract][Full Text] [Related]
11. Functional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome.
Tepper Á; Cuiza A; Alliende LM; Mena C; Ramirez-Mahaluf JP; Iruretagoyena B; Ornstein C; Fritsch R; Nachar R; González-Valderrama A; Undurraga J; Cruz JP; Tejos C; Fornito A; Repetto G; Crossley N
Schizophr Bull; 2022 Mar; 48(2):485-494. PubMed ID: 34931688
[TBL] [Abstract][Full Text] [Related]
12. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
[TBL] [Abstract][Full Text] [Related]
13. An interictal schizophrenia-like psychosis in an adult patient with 22q11.2 deletion syndrome.
Tastuzawa Y; Sekikawa K; Suda T; Matsumoto H; Otabe H; Nonoyama S; Yoshino A
Epilepsy Behav Case Rep; 2015; 3():36-8. PubMed ID: 25870791
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
Mekori-Domachevsky E; Taler M; Weinberger R; Guri Y; Dar S; Shani S; Dekel I; Weizman A; Gothelf D
Schizophr Res; 2021 May; 231():164-169. PubMed ID: 33866261
[TBL] [Abstract][Full Text] [Related]
15. Shyness discriminates between children with 22q11.2 deletion syndrome and Williams syndrome and predicts emergence of psychosis in 22q11.2 deletion syndrome.
Schonherz Y; Davidov M; Knafo A; Zilkha H; Shoval G; Zalsman G; Frisch A; Weizman A; Gothelf D
J Neurodev Disord; 2014 Feb; 6(1):3. PubMed ID: 24517288
[TBL] [Abstract][Full Text] [Related]
16. Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism.
Graf WD; Unis AS; Yates CM; Sulzbacher S; Dinulos MB; Jack RM; Dugaw KA; Paddock MN; Parson WW
Neurology; 2001 Aug; 57(3):410-6. PubMed ID: 11502905
[TBL] [Abstract][Full Text] [Related]
17. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
[TBL] [Abstract][Full Text] [Related]
18. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
Elife; 2022 Aug; 11():. PubMed ID: 36039635
[TBL] [Abstract][Full Text] [Related]
19. Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.
Shapiro DI; Cubells JF; Ousley OY; Rockers K; Walker EF
Schizophr Res; 2011 Jun; 129(1):20-8. PubMed ID: 21507614
[TBL] [Abstract][Full Text] [Related]
20. Neurological manifestation of 22q11.2 deletion syndrome.
Bayat M; Bayat A
Neurol Sci; 2022 Mar; 43(3):1695-1700. PubMed ID: 35039989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
